Results 31 to 40 of about 9,640,042 (194)
Lipoxidation in cardiovascular diseases
Redox Biology, 2019 Lipids can go through lipid peroxidation, an endogenous chain reaction that consists in the oxidative degradation of lipids leading to the generation of a wide variety of highly reactive carbonyl species (RCS), such as short-chain carbonyl derivatives and oxidized truncated phospholipids.
Gianazza, Erica +3 more
openaire +3 more sources
Case Reports in Surgery, 2020 Cutaneous-pericardial fistula is a rare complication of transapical aortic valve replacement; only a few cases are reported in the literature. It is part of a wide range of surgical site infection manifestations that could emerge after surgery.
Andrei Tarus +5 more
doaj +1 more source
CHA2DS2-VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization [PDF]
Journal of Cardiovascular and Thoracic Research, 2022 Introduction: Slow flow/no reflow (SF/NR) phenomenon during emergency percutaneous revascularization is a feared complication associated with increased risk of adverse outcomes.CHA2DS2-VASc score has been proposed for the risk stratification but a very ...
Abdul Hakeem Shaikh +9 more
doaj +1 more source
Machine learning prediction in cardiovascular diseases: a meta-analysis
Scientific Reports, 2020 Several machine learning (ML) algorithms have been increasingly utilized for cardiovascular disease prediction. We aim to assess and summarize the overall predictive ability of ML algorithms in cardiovascular diseases. A comprehensive search strategy was
Chayakrit Krittanawong +14 more
semanticscholar +1 more source
Вестник трансплантологии и искусственных органов, 2022 Carotid endarterectomy (CEA) with patch angioplasty is the most effective treatment for carotid artery stenosis. However, the use of existing vascular patches is often associated with thrombosis, restenosis, calcification and other complications ...
L. V. Antonova +12 more
doaj +1 more source
COPD and Cardiovascular Disease
Pulmonology, 2019 COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated.
André, S +6 more
openaire +7 more sources
BMJ Open, 2023 Objective This study aimed to assess the International Quality Improvement Collaborative single-site data from a developing country to identify trends in outcomes and factors associated with poor outcomes.Design Retrospective descriptive study.Setting ...
Muneer Amanullah +6 more
doaj +1 more source
Circulation Genomic and Precision Medicine, 2020 Advances in human genetics are improving the understanding of a variety of inherited cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, and lipid disorders such as familial hypercholesterolemia.
K. Musunuru +8 more
semanticscholar +1 more source
Immunotherapy for cardiovascular disease
European Heart Journal, 2019 Abstract The outcomes of the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial have unequivocally proven that inflammation is a key driver of atherosclerosis and that targeting inflammation, in this case by using an anti-interleukin-1β antibody, improves cardiovascular disease (CVD) outcomes.
Esther Lutgens +7 more
openaire +3 more sources
Pseudogenes in Cardiovascular Disease [PDF]
Frontiers in Molecular Biosciences, 2021 Cardiovascular disease is the main disease that affects human life span. In recent years, the disease has been increasingly addressed at the molecular levels, for example, pseudogenes are now known to be involved in the pathogenesis and development of cardiovascular diseases.
Songtao An +5 more
openaire +3 more sources